Abiopharma

The Company, through its subsidiaries (collectively, the “Group”), is principally engaged in the medical development business as an integrated healthcare services and facilities provider. The Group owns, manages and develops its assets portfolio through a series of acquisitions of operating assets, development and re-development projects, as well as land banks earmarked for development. The Group’s portfolio of assets includes or will include: (a) medical real estate (such as hospital facilities); (b) healthcare-related assets (such as nursing homes and maternity homes); and (c) integrated mixed-use developments (such as developments with medical real estate/healthcare-related assets, retail space and/or service residences), which are operational, under development or earmarked for development.
 

Additional info from SGX:

The Company, through its subsidiaries (collectively, the “Group”), is principally engaged in the medical development business as an integrated healthcare services and facilities provider. The Group owns, manages and develops its assets portfolio through a series of acquisitions of operating assets, development and re-development projects, as well as land banks earmarked for development. The Group’s portfolio of assets includes or will include: (a) medical real estate (such as hospital facilities); (b) healthcare-related assets (such as nursing homes and maternity homes); and (c) integrated mixed-use developments (such as developments with medical real estate/healthcare-related assets, retail space and/or service residences), which are operational, under development or earmarked for development.